$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

$amrx Overview Financials Valuation SEC Filings Company Website

2017 Q4 Form 10-K Financial Statement

#000172312819000028 Filed on March 01, 2019

Income Statement

Concept	2017 Q4	2017 Q3	2017 Q2
Revenue	$0.00	$254.7M	$259.9M
YoY Change	-100.0%	11.77%	50.56%
Cost Of Revenue	$170.4M	$119.7M	$136.1M
YoY Change	-52.63%	-69.56%	36.68%
Gross Profit	$151.4M	$135.0M	$123.7M
YoY Change	-193.87%	-181.63%	69.5%
Gross Profit Margin		53.0%	47.61%
Selling, General & Admin	$64.00M	$27.44M	$26.94M
YoY Change	11.11%	-50.11%	-40.0%
% of Gross Profit	42.27%	20.32%	21.77%
Research & Development	$15.70M	$41.32M	$47.18M
YoY Change	-23.41%	105.59%	117.44%
% of Gross Profit	10.37%	30.61%	38.13%
Depreciation & Amortization	$24.00M	$10.68M	$9.650M
YoY Change	-4.76%	-60.0%	-53.38%
% of Gross Profit	15.85%	7.91%	7.8%
Operating Expenses	$0.00	$68.76M	$74.12M
YoY Change	-100.0%	-8.56%	11.13%
Operating Profit	$151.4M	$78.75M	$44.60M
YoY Change	-163.25%	-132.73%	607.98%
Interest Expense	$24.40M	-$19.22M	-$17.73M
YoY Change	-282.09%	76.31%	118.84%
% of Operating Profit	16.11%	-24.4%	-39.74%
Other Income/Expense, Net	-$300.0K	-$52.37M	-$5.003M
YoY Change	-104.76%	12992.25%	2401.5%
Pretax Income	-$310.1M	$26.38M	$39.60M
YoY Change	14.43%	-109.29%	-1090.0%
Income Tax	$0.00	-$738.0K	$1.852M
% Of Pretax Income		-2.8%	4.68%
Net Earnings	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Net Earnings / Revenue		0.0%	0.0%
Basic Earnings Per Share	$0.00	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2017 Q4	2017 Q3	2017 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$181.8M	$157.7M	$171.4M
YoY Change	0.94%	-32.06%	-53.27%
Cash & Equivalents	$74.17M	$19.35M	$48.22M
Short-Term Investments
Other Short-Term Assets	$53.40M	$60.70M	$36.90M
YoY Change	190.22%	-0.98%	51.85%
Inventory	$284.0M	$172.8M	$200.4M
Prepaid Expenses
Receivables	$351.4M	$242.0M	$219.7M
Other Receivables	$15.15M	$0.00	$0.00
Total Short-Term Assets	$771.9M	$633.2M	$628.5M
YoY Change	22.32%	-9.62%	-19.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$486.8M	$223.2M	$232.5M
YoY Change	108.55%	-1.93%	4.03%
Goodwill	$26.44M
YoY Change	-7.02%
Intangibles	$44.60M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$11.26M	$75.40M	$92.20M
YoY Change	-91.39%	-17.95%	54.7%
Total Long-Term Assets	$570.0M	$1.016B	$1.073B
YoY Change	-52.18%	-28.41%	-0.06%
TOTAL ASSETS
Total Short-Term Assets	$771.9M	$633.2M	$628.5M
Total Long-Term Assets	$570.0M	$1.016B	$1.073B
Total Assets	$1.342B	$1.649B	$1.701B
YoY Change	-26.39%	-22.2%	-8.04%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$70.01M	$53.70M	$56.60M
YoY Change	18.67%	-13.25%	12.08%
Accrued Expenses	$248.1M	$249.3M	$262.9M
YoY Change	1.39%	-2.2%	22.05%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$89.17M	$17.80M	$17.80M
YoY Change	403.79%	0.56%
Total Short-Term Liabilities	$296.9M	$349.0M	$359.2M
YoY Change	-7.6%	4.33%	35.09%
LONG-TERM LIABILITIES
Long-Term Debt	$1.355B	$767.9M	$766.5M
YoY Change	66.6%	-5.48%	76.09%
Other Long-Term Liabilities	$7.793M	$48.30M	$48.60M
YoY Change	-87.86%	-29.9%	30.65%
Total Long-Term Liabilities	$1.421B	$816.2M	$815.1M
YoY Change	61.85%	-7.39%	72.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$296.9M	$349.0M	$359.2M
Total Long-Term Liabilities	$1.421B	$816.2M	$815.1M
Total Liabilities	$0.00	$1.167B	$1.176B
YoY Change	-100.0%	-4.0%	51.41%
SHAREHOLDERS EQUITY
Retained Earnings	-$382.8M
YoY Change
Common Stock	$10.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$0.00	$481.9M	$525.4M
YoY Change
Total Liabilities & Shareholders Equity	$1.342B	$1.649B	$1.701B
YoY Change	-26.39%	-22.2%	-8.04%

Cashflow Statement

Concept	2017 Q4	2017 Q3	2017 Q2
OPERATING ACTIVITIES
Net Income	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%	-100.0%
Depreciation, Depletion And Amortization	$24.00M	$10.68M	$9.650M
YoY Change	-4.76%	-60.0%	-53.38%
Cash From Operating Activities	$0.00	-$11.40M	$18.40M
YoY Change	-100.0%	-114.2%	-133.39%
INVESTING ACTIVITIES
Capital Expenditures	-$2.600M	-$5.200M	-$10.30M
YoY Change	-85.14%	-54.39%	7.29%
Acquisitions
YoY Change
Other Investing Activities	-$4.400M	$8.800M	$12.20M
YoY Change	-6.38%	-101.5%	-25.15%
Cash From Investing Activities	$0.00	$3.600M	$1.900M
YoY Change	-100.0%	-100.6%	-71.64%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$0.00	-5.500M	-6.000M
YoY Change	-100.0%	-101.44%	-300.0%
NET CHANGE
Cash From Operating Activities	$0.00	-11.40M	18.40M
Cash From Investing Activities	$0.00	3.600M	1.900M
Cash From Financing Activities	$0.00	-5.500M	-6.000M
Net Change In Cash	$0.00	-13.30M	14.30M
YoY Change	-100.0%	-90.15%	-131.5%
FREE CASH FLOW
Cash From Operating Activities	$0.00	-$11.40M	$18.40M
Capital Expenditures	-$2.600M	-$5.200M	-$10.30M
Free Cash Flow	$2.600M	-$6.200M	$28.70M
YoY Change	-196.3%	-106.76%	-163.08%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q4	amrx	Accrued Sales Rebates Current AccruedSalesRebatesCurrent	12911000	USD
CY2018Q4	amrx	Accrued Sales Rebates Current AccruedSalesRebatesCurrent	74202000	USD
CY2017Q4	amrx	Accrued Sales Returns Allowance Current AccruedSalesReturnsAllowanceCurrent	45175000	USD
CY2018Q4	amrx	Accrued Sales Returns Allowance Current AccruedSalesReturnsAllowanceCurrent	154503000	USD
CY2017Q4	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	475935000	USD
CY2018Q4	amrx	Allowance For Accounts Receivable Current AllowanceForAccountsReceivableCurrent	868093000	USD
CY2016	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-110638000	USD
CY2017	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-109920000	USD
CY2018	amrx	Business Acquisition Pro Forma Net Income Loss Attributable To Common Shareholders BusinessAcquisitionProFormaNetIncomeLossAttributableToCommonShareholders	-30270000	USD
CY2016	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	70000	USD
CY2017	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	9403000	USD
CY2018	amrx	Business Combination Acquisition Related Costs Transaction Related And Integration Expense BusinessCombinationAcquisitionRelatedCostsTransactionRelatedAndIntegrationExpense	221818000	USD
CY2017Q4	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	20408000	USD
CY2018Q4	amrx	Cash Discount Allowances Current CashDiscountAllowancesCurrent	36157000	USD
CY2016	amrx	Concentration Risk Number Of Largest Customers ConcentrationRiskNumberOfLargestCustomers	3	customer
CY2017	amrx	Concentration Risk Number Of Largest Customers ConcentrationRiskNumberOfLargestCustomers	3	customer
CY2018	amrx	Concentration Risk Number Of Largest Customers ConcentrationRiskNumberOfLargestCustomers	3	customer
CY2017Q4	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	453703000	USD
CY2018Q4	amrx	Contract Charge Backs And Sales Volume Allowances Current ContractChargeBacksAndSalesVolumeAllowancesCurrent	829596000	USD
CY2018Q2	amrx	Deferred Tax Asset Basis Difference In Investment Portion Attributable To Acquirer Prior To Business Combination DeferredTaxAssetBasisDifferenceInInvestmentPortionAttributableToAcquirerPriorToBusinessCombination	306000000	USD
CY2018Q2	amrx	Deferred Tax Asset Operating Loss Carryforward Portion Attributable To Acquirer Prior To Business Combination DeferredTaxAssetOperatingLossCarryforwardPortionAttributableToAcquirerPriorToBusinessCombination	55000000	USD
CY2017Q4	amrx	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	949000	USD
CY2018Q4	amrx	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	900000	USD
CY2017Q4	amrx	Deferred Tax Assets Partnership Interest DeferredTaxAssetsPartnershipInterest	0	USD
CY2018Q4	amrx	Deferred Tax Assets Partnership Interest DeferredTaxAssetsPartnershipInterest	240044000	USD
CY2017Q4	amrx	Deferred Tax Assets Projected Imputed Interest On Tax Receivable Agreement DeferredTaxAssetsProjectedImputedInterestOnTaxReceivableAgreement	0	USD
CY2018Q4	amrx	Deferred Tax Assets Projected Imputed Interest On Tax Receivable Agreement DeferredTaxAssetsProjectedImputedInterestOnTaxReceivableAgreement	9838000	USD
CY2017Q4	amrx	Deferred Tax Assets Tax Credit Carryforwards Interest DeferredTaxAssetsTaxCreditCarryforwardsInterest	0	USD
CY2018Q4	amrx	Deferred Tax Assets Tax Credit Carryforwards Interest DeferredTaxAssetsTaxCreditCarryforwardsInterest	33789000	USD
CY2016	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	33016000	USD
CY2017	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	45936000	USD
CY2018	amrx	Depreciation Depletion And Amortization Excluding Amortization Of Debt Issuance Costs DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtIssuanceCosts	137403000	USD
	us-gaap	Stockholders Equity Other StockholdersEquityOther	1785000	USD
CY2016	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	0	USD
CY2017	amrx	Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent	0.106
CY2018	amrx	Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent	-0.123
CY2018Q4	amrx	Dueto Related Parties Tax Distribution DuetoRelatedPartiesTaxDistribution	13000000	USD
CY2016	amrx	Effective Income Tax Rate Reconciliation Loss No Benefit Recognized Percent EffectiveIncomeTaxRateReconciliationLossNoBenefitRecognizedPercent	0.082
CY2016	amrx	Profit Sharing Expense ProfitSharingExpense	0	USD
CY2017	amrx	Profit Sharing Expense ProfitSharingExpense	0	USD
CY2016	amrx	Repayments Of Financing Obligation Related Party Debt RepaymentsOfFinancingObligationRelatedPartyDebt	259000	USD
CY2018Q4	amrx	Finite Lived Intangible Assets Amortization Expense Year Six FiniteLivedIntangibleAssetsAmortizationExpenseYearSix	526243000	USD
CY2017Q4	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	0	USD
CY2018Q4	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	192884000	USD
CY2018Q2	amrx	Liabilities Under Tax Receivable Agreement Noncurrent LiabilitiesUnderTaxReceivableAgreementNoncurrent	193000000	USD
CY2016	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	207378000	USD
CY2017	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	167648000	USD
CY2018	amrx	Net Income Loss Attributable To Acquirer Prior To Business Combination NetIncomeLossAttributableToAcquirerPriorToBusinessCombination	-148806000	USD
	amrx	Noncontrolling Interest Decreasefrom Distributionsto Noncontrolling Interest Holders Tax Distribution NoncontrollingInterestDecreasefromDistributionstoNoncontrollingInterestHoldersTaxDistribution	48955000	USD
CY2018Q4	amrx	Noncontrolling Interest Number Of Subsidiaries Acquired NoncontrollingInterestNumberOfSubsidiariesAcquired	1	subsidiary
CY2018	amrx	Number Of Product Families NumberOfProductFamilies	200	product
CY2016	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	3047000	USD
CY2017	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	-1435000	USD
CY2018	amrx	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Acquirer Prior To Business Combination OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToAcquirerPriorToBusinessCombination	1721000	USD
CY2017Q4	amrx	Prepaid Regulatory Fees Current PrepaidRegulatoryFeesCurrent	5926000	USD
CY2018Q4	amrx	Prepaid Regulatory Fees Current PrepaidRegulatoryFeesCurrent	4924000	USD
CY2016	amrx	Proceeds From Purchase Of Noncontrolling Interests ProceedsFromPurchaseOfNoncontrollingInterests	0	USD
CY2017	amrx	Proceeds From Purchase Of Noncontrolling Interests ProceedsFromPurchaseOfNoncontrollingInterests	0	USD
CY2018	amrx	Proceeds From Purchase Of Noncontrolling Interests ProceedsFromPurchaseOfNoncontrollingInterests	3485000	USD
CY2018	amrx	Profit Share And Transaction Related Bonus Expense ProfitShareAndTransactionRelatedBonusExpense	187000000	USD
CY2018	amrx	Profit Sharing Expense ProfitSharingExpense	158757000	USD
CY2018	amrx	Profit Sharing Expense ProfitSharingExpense	159000000	USD
CY2018	amrx	Redeemable Noncontrolling Interest Decrease From Repurchase Of Temporary Equity RedeemableNoncontrollingInterestDecreaseFromRepurchaseOfTemporaryEquity	11775000	USD
CY2017	amrx	Repayments Of Financing Obligation Related Party Debt RepaymentsOfFinancingObligationRelatedPartyDebt	274000	USD
CY2018	amrx	Repayments Of Financing Obligation Related Party Debt RepaymentsOfFinancingObligationRelatedPartyDebt	243000	USD
CY2017Q4	amrx	Sales Rebate Reimbursement Current SalesRebateReimbursementCurrent	15000000	USD
CY2018Q4	amrx	Sales Rebate Reimbursement Current SalesRebateReimbursementCurrent	15000000	USD
CY2018	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted	3002669	shares
CY2018	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConverted	3000000	shares
CY2018	amrx	Sharebased Compensation Arrangement By Sharebased Payment Award Options Converted Weighted Average Exercise Price SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsConvertedWeightedAverageExercisePrice	18.90
CY2018Q2	amrx	Shares Repurchased Percentage SharesRepurchasedPercentage	0.15
CY2018Q1	amrx	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	100000	USD
CY2018Q4	amrx	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	100000	USD
CY2018	amrx	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Benefit TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseBenefit	200000	USD
CY2018	amrx	Tax Cuts And Jobs Act Of2017 Incomplete Accounting Provisional Income Tax Expense Global Intangible Low Taxed Income TaxCutsAndJobsActOf2017IncompleteAccountingProvisionalIncomeTaxExpenseGlobalIntangibleLowTaxedIncome	400000	USD
CY2016	amrx	Tax Distribution To Noncontrolling Interest TaxDistributionToNoncontrollingInterest	0	USD
CY2017	amrx	Tax Distribution To Noncontrolling Interest TaxDistributionToNoncontrollingInterest	0	USD
CY2018	amrx	Tax Distribution To Noncontrolling Interest TaxDistributionToNoncontrollingInterest	13412000	USD
CY2016	amrx	Tax Distribution To Noncontrolling Interest Financing Activities TaxDistributionToNoncontrollingInterestFinancingActivities	0	USD
CY2017	amrx	Tax Distribution To Noncontrolling Interest Financing Activities TaxDistributionToNoncontrollingInterestFinancingActivities	0	USD
CY2018	amrx	Tax Distribution To Noncontrolling Interest Financing Activities TaxDistributionToNoncontrollingInterestFinancingActivities	35543000	USD
CY2016	amrx	Transaction Costs Paid By Parent TransactionCostsPaidByParent	0	USD
CY2017	amrx	Transaction Costs Paid By Parent TransactionCostsPaidByParent	8561000	USD
CY2018	amrx	Transaction Costs Paid By Parent TransactionCostsPaidByParent	0	USD
CY2017	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	0	USD
CY2018	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2018	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2018Q2	dei	Entity Public Float EntityPublicFloat	1970292676	USD
CY2018	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2018	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2018	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	27742000	USD
CY2018	amrx	Transaction Related Bonus Expense TransactionRelatedBonusExpense	28000000	USD
CY2016	amrx	Valuation Allowance Deferred Tax Asset Decrease Divestitures ValuationAllowanceDeferredTaxAssetDecreaseDivestitures	0	USD
CY2017	amrx	Valuation Allowance Deferred Tax Asset Decrease Divestitures ValuationAllowanceDeferredTaxAssetDecreaseDivestitures	23900000	USD
CY2018	amrx	Valuation Allowance Deferred Tax Asset Decrease Divestitures ValuationAllowanceDeferredTaxAssetDecreaseDivestitures	0	USD
CY2016	amrx	Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences	19664000	USD
CY2017	amrx	Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences	23286000	USD
CY2018	amrx	Valuation Allowance Deferred Tax Asset Increase Decrease Current Year Net Operating Losses And Temporary Differences ValuationAllowanceDeferredTaxAssetIncreaseDecreaseCurrentYearNetOperatingLossesAndTemporaryDifferences	-382000	USD
CY2018	dei	Amendment Flag AmendmentFlag	false
CY2018	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2018	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018	dei	Document Period End Date DocumentPeriodEndDate	2018-12-31
CY2018	dei	Document Type DocumentType	10-K
CY2018	dei	Entity Central Index Key EntityCentralIndexKey	0001723128
CY2018	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018	dei	Entity Registrant Name EntityRegistrantName	Amneal Pharmaceuticals, Inc.
CY2018	dei	Entity Shell Company EntityShellCompany	false
CY2018	dei	Entity Small Business EntitySmallBusiness	false
CY2018	dei	Trading Symbol TradingSymbol	AMRX
CY2017Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	194779000	USD
CY2018Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	514440000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	70013000	USD
CY2018Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	114846000	USD
CY2017Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	827302000	USD
CY2018Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	1349588000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	351367000	USD
CY2018Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	481495000	USD
CY2017Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	938000	USD
CY2018Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4555000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	2970000	USD
CY2018Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	23639000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	156370000	USD
CY2018Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	209436000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14232000	USD
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7755000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8562000	USD
CY2018Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	530438000	USD
	us-gaap	Adjustments To Additional Paid In Capital Increase In Carrying Amount Of Redeemable Preferred Stock AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock	11708000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8840000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2018Q4	us-gaap	Assets Assets	4352736000	USD
CY2017	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-340223000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-163915000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	0	USD
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8840000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1824000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2340000	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3055000	USD
CY2016	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	3000000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	4585000	USD
CY2017	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5000000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	5859000	USD
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	6000000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3702000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3974000	USD
CY2018	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	72986000	USD
CY2016	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2017	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2018	us-gaap	Asset Impairment Charges AssetImpairmentCharges	39259000	USD
CY2017Q4	us-gaap	Assets Assets	1341889000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	771933000	USD
CY2018Q4	us-gaap	Assets Current AssetsCurrent	1286644000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-535087000	USD
CY2016	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1842654000	USD
CY2017	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1809441000	USD
CY2018	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1839083000	USD
CY2016	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	70000	USD
CY2017	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	9403000	USD
CY2018	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	35319000	USD
CY2017Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	40000000	USD
CY2018Q4	us-gaap	Capital Lease Obligations CapitalLeaseObligations	39000000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	300000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	311000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	300000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	266000	USD
CY2017Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	39987000	USD
CY2018Q4	us-gaap	Capital Lease Obligations Noncurrent CapitalLeaseObligationsNoncurrent	39083000	USD
CY2018Q4	us-gaap	Capital Leased Assets Number Of Units CapitalLeasedAssetsNumberOfUnits	2	building
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due CapitalLeasesFutureMinimumPaymentsDue	134566000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Current CapitalLeasesFutureMinimumPaymentsDueCurrent	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Five Years CapitalLeasesFutureMinimumPaymentsDueInFiveYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Four Years CapitalLeasesFutureMinimumPaymentsDueInFourYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Three Years CapitalLeasesFutureMinimumPaymentsDueInThreeYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due In Two Years CapitalLeasesFutureMinimumPaymentsDueInTwoYears	5474000	USD
CY2018Q4	us-gaap	Capital Leases Future Minimum Payments Due Thereafter CapitalLeasesFutureMinimumPaymentsDueThereafter	107196000	USD
CY2017Q4	us-gaap	Common Unit Issued CommonUnitIssued	189000000	shares
CY2017Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	189000000	shares
CY2016	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	420770000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	0	USD
CY2017	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	507476000	USD
CY2018	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	946588000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2018Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Unit Authorized CommonUnitAuthorized	189000000	shares
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27367000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	74166000	USD
CY2018Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	213394000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65106000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	37546000	USD
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	77922000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	218779000	USD
CY2016	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27560000	USD
CY2017	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	40376000	USD
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	140857000	USD
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-23337000	USD
CY2017Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1851000	USD
CY2018Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	2142000	USD
CY2018Q1	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	4977000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2299000	USD
CY2016	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5274000	USD
CY2017	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1256000	USD
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	5721000	USD
CY2016	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	5274000	USD
CY2017	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1256000	USD
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	8020000	USD
CY2017Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1453160000	USD
CY2018Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2686500000	USD
CY2018	us-gaap	Deferred Compensation Arrangement With Individual Contributions By Employer DeferredCompensationArrangementWithIndividualContributionsByEmployer	0	USD
CY2016	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2017	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2967000	USD
CY2016Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	7000000	USD
CY2017Q2	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	3000000	USD
CY2017Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	8715000	USD
CY2018Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	34453000	USD
CY2016	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	121000	USD
CY2017	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	742000	USD
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-6472000	USD
CY2017Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	898000	USD
CY2017Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	16210000	USD
CY2018Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	373159000	USD
CY2016	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	121000	USD
CY2017	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	742000	USD
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9439000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	3287000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1178000	USD
CY2017Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	2491000	USD
CY2018Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1178000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	122000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	1553000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	43311000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	414394000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	371981000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1694000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	373159000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	34889000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	107942000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	6366000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	16030000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	985000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	4298000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22567000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	42231000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41617000	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	41235000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1593000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	0	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	1178000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	3287000	USD
CY2018Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	0	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	2000000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	3000000	USD
CY2018	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	7000000	USD
CY2016	us-gaap	Depreciation Depreciation	29314000	USD
CY2017	us-gaap	Depreciation Depreciation	41962000	USD
CY2018	us-gaap	Depreciation Depreciation	64417000	USD
CY2016	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	0	USD
CY2017	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-29232000	USD
CY2018	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-2958000	USD
	us-gaap	Distribution Made To Limited Partner Cash Distributions Declared DistributionMadeToLimitedPartnerCashDistributionsDeclared	191560000	USD
CY2016	us-gaap	Distribution Made To Limited Partner Cash Distributions Declared DistributionMadeToLimitedPartnerCashDistributionsDeclared	200615000	USD
CY2017	us-gaap	Distribution Made To Limited Partner Cash Distributions Declared DistributionMadeToLimitedPartnerCashDistributionsDeclared	375265000	USD
CY2016Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2017Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	0	USD
CY2018Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	8562000	USD
CY2016	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted
CY2018	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.16
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2018Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
CY2016	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1481000	USD
CY2017	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-242000	USD
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-670000	USD
CY2018Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	0	USD
CY2017Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2017Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2018Q4	us-gaap	Due From Related Parties Current DueFromRelatedPartiesCurrent	830000	USD
CY2017Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	12622000	USD
CY2018Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	17695000	USD
CY2017Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	15043000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2017Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2017Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2018Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.15
CY2018Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2018Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
CY2018Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2018Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.15
CY2018Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.025
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.012
CY2018	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.007
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0
CY2018	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.054
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.065
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.063
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.003
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.029
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.006
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.000
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	0.000
CY2018	us-gaap	Effective Income Tax Rate Reconciliation Tax Settlements State And Local EffectiveIncomeTaxRateReconciliationTaxSettlementsStateAndLocal	-0.011
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23954000	USD
CY2018Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	77066000	USD
CY2018Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	41000000	USD
CY2018	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y3M12D
CY2017Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	19447000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	91597000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	123497000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	127249000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	149053000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	146843000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	171323000	USD
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-202722000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	5395000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1998000	USD
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1419000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	130154000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	62896000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1294636000	USD
CY2017Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	43449000	USD
CY2018Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1203039000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-14108000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	29092000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-19701000	USD
CY2016	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-12162000	USD
CY2017	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	30823000	USD
CY2018	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-18582000	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	11000000	USD
CY2016	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	11000000	USD
CY2017	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	29000000	USD
CY2017	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	29312000	USD
CY2018	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	22000000	USD
CY2018	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	22300000	USD
CY2017Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3000000	USD
CY2016	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-2532000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-19667000	USD
CY2018	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-20000000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	28441000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	26444000	USD
CY2018Q4	us-gaap	Goodwill Goodwill	426226000	USD
CY2017	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	USD
CY2018	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	401488000	USD
CY2017	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	1898000	USD
CY2018	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-1706000	USD
CY2017	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3895000	USD
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2016	us-gaap	Gross Profit GrossProfit	597455000	USD
CY2017Q1	us-gaap	Gross Profit GrossProfit	116016000	USD
CY2017Q2	us-gaap	Gross Profit GrossProfit	123733000	USD
CY2017Q3	us-gaap	Gross Profit GrossProfit	135013000	USD
CY2017Q4	us-gaap	Gross Profit GrossProfit	151416000	USD
CY2017	us-gaap	Gross Profit GrossProfit	526178000	USD
CY2018Q1	us-gaap	Gross Profit GrossProfit	144595000	USD
CY2018Q2	us-gaap	Gross Profit GrossProfit	178295000	USD
CY2018Q3	us-gaap	Gross Profit GrossProfit	200105000	USD
CY2018Q4	us-gaap	Gross Profit GrossProfit	193408000	USD
CY2018	us-gaap	Gross Profit GrossProfit	716403000	USD
CY2016	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2017	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	0	USD
CY2016	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-307000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31826000	USD
CY2018	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42875000	USD
CY2016	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4922000	USD
CY2017	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	5780000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2042000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25305000	USD
CY2017	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	5485000	USD
CY2018	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-10928000	USD
CY2017Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	0	USD
CY2018Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	29625000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	6265000	USD
CY2018	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	47928000	USD
CY2016	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	4303000	USD
CY2017	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	8208000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	214821000	USD
CY2018	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-19198000	USD
CY2018	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-14113000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	42587000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	18105000	USD
CY2018	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-55212000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	122482000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-35255000	USD
CY2018	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-89084000	USD
CY2017Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	1150000	USD
CY2018Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	451930000	USD
CY2017Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	64046000	USD
CY2018Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	1746566000	USD
CY2017Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	44599000	USD
CY2018Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1654969000	USD
CY2016	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-55283000	USD
CY2017	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-71061000	USD
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-143571000	USD
CY2016	us-gaap	Interest Paid Net InterestPaidNet	50569000	USD
CY2017	us-gaap	Interest Paid Net InterestPaidNet	65086000	USD
CY2018	us-gaap	Interest Paid Net InterestPaidNet	131505000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	105841000	USD
CY2018Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	221413000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	284038000	USD
CY2018Q4	us-gaap	Inventory Net InventoryNet	457219000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	140051000	USD
CY2018Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	181654000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	38146000	USD
CY2018Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	54152000	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	9235000	USD
CY2017	us-gaap	Inventory Write Down InventoryWriteDown	3771000	USD
CY2018	us-gaap	Inventory Write Down InventoryWriteDown	44539000	USD
CY2016	us-gaap	Legal Fees LegalFees	25728000	USD
CY2017	us-gaap	Legal Fees LegalFees	20518000	USD
CY2018	us-gaap	Legal Fees LegalFees	16261000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1341889000	USD
CY2018Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4352736000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	296883000	USD
CY2018Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	21449000	USD
CY2017Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	89171000	USD
CY2017Q4	us-gaap	Members Equity Attributable To Noncontrolling Interest MembersEquityAttributableToNoncontrollingInterest	10157000	USD
CY2018Q4	us-gaap	Liabilities Current LiabilitiesCurrent	553850000	USD
CY2017Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	1420588000	USD
CY2018Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2902523000	USD
CY2015Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-186873000	USD
CY2016Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-175945000	USD
CY2017Q4	us-gaap	Limited Liability Company Llc Members Equity Including Portion Attributable To Noncontrolling Interest LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest	-375582000	USD
CY2017Q4	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2018Q4	us-gaap	Litigation Reserve LitigationReserve	15000000	USD
CY2017Q4	us-gaap	Long Term Debt LongTermDebt	1444445000	USD
CY2018Q4	us-gaap	Long Term Debt LongTermDebt	2652047000	USD
CY2017Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	89171000	USD
CY2018Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	21449000	USD
CY2017Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1355274000	USD
CY2018Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	2630598000	USD
CY2017Q4	us-gaap	Members Capital MembersCapital	2716000	USD
CY2017Q4	us-gaap	Members Equity MembersEquity	-385739000	USD
CY2018Q4	us-gaap	Minority Interest MinorityInterest	391613000	USD
CY2016	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	973000	USD
CY2017	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	865000	USD
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	49000000	USD
	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	3485000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-19495000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-95015000	USD
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	287675000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-124606000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98554000	USD
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-396378000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	115060000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	234187000	USD
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	250230000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	0	USD
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-19744000	USD
CY2016	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2048000	USD
CY2017	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	1677000	USD
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-32753000	USD
CY2016	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2017Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2017Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2017Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2018Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	6952000	USD
CY2018Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-8768000	USD
CY2018	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	11295000	USD
CY2016	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-20920000	USD
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-52661000	USD
CY2016	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	USD
CY2017	us-gaap	Noncash Merger Related Costs NoncashMergerRelatedCosts	0	USD
CY2017	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	14758000	USD
CY2018	us-gaap	Noncash Or Part Noncash Acquisition Payables Assumed1 NoncashOrPartNoncashAcquisitionPayablesAssumed1	0	USD
CY2016	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	USD
CY2017	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	1936000	USD
CY2018	us-gaap	Noncash Or Part Noncash Divestiture Amount Of Consideration Received1 NoncashOrPartNoncashDivestitureAmountOfConsiderationReceived1	0	USD
	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	2518000	USD
	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	360000	USD
CY2017	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2018Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	0	USD
CY2018Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19104000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-70060000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-73780000	USD
CY2018	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-183049000	USD
CY2018	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	284881000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	245103000	USD
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	-19673000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	97561000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	25885000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	10043000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	10329000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	11105000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	12071000	USD
CY2018Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	28128000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	14000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	17000000	USD
CY2018	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	18000000	USD
CY2017Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	23818000	USD
CY2018Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37352000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11257000	USD
CY2018Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	67592000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1721000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-5673000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3047000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-1435000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3952000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	USD
CY2018Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38780000	USD
CY2016	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-197000	USD
CY2018Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	16979000	USD
CY2017	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-9935000	USD
CY2018	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1866000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-669000	USD
	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	27742000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-47000	USD
CY2018	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2848000	USD
CY2017	us-gaap	Partners Capital Account Contributions PartnersCapitalAccountContributions	8603000	USD
CY2016	us-gaap	Partners Capital Account Return Of Capital PartnersCapitalAccountReturnOfCapital	43000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	0	USD
	us-gaap	Partners Capital Account Unit Based Compensation PartnersCapitalAccountUnitBasedCompensation	158757000	USD
CY2016	us-gaap	Payments For Repurchase Of Equity PaymentsForRepurchaseOfEquity	5000	USD
CY2017Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	16315000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-2417000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7793000	USD
CY2018Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	42396000	USD
CY2018Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	32164000	USD
CY2017Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	15150000	USD
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-3256000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	USD
CY2016	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2017	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	USD
CY2018Q2	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	12000000	USD
CY2018	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	11775000	USD
CY2016	us-gaap	Payments Of Dividends PaymentsOfDividends	200615000	USD
CY2017	us-gaap	Payments Of Dividends PaymentsOfDividends	375265000	USD
CY2018	us-gaap	Payments Of Dividends PaymentsOfDividends	182998000	USD
CY2018	us-gaap	Payments Of Dividends PaymentsOfDividends	183000000	USD
CY2016	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6506000	USD
CY2017	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5026000	USD
CY2018	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	54955000	USD
CY2018Q4	us-gaap	Payments To Acquire Additional Interest In Subsidiaries PaymentsToAcquireAdditionalInterestInSubsidiaries	3500000	USD
CY2016	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2017	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2018	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	324634000	USD
CY2016	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1850000	USD
CY2017	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19500000	USD
CY2018	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	14000000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	122756000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	94771000	USD
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83088000	USD
CY2018Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2018Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2018Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000	shares
CY2018Q4	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25000000	USD
CY2016	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2017	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2018	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	25344000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2018Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	50000000	USD
CY2018	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-75000000	USD
CY2018Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	128321000	USD
CY2016	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-25000000	USD
CY2017Q4	us-gaap	Prepaid Insurance PrepaidInsurance	3154000	USD
CY2018Q4	us-gaap	Prepaid Insurance PrepaidInsurance	6094000	USD
CY2017	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	40000	USD
CY2018	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	27742000	USD
CY2016	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2017	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	15717000	USD
CY2018	us-gaap	Proceeds From Divestiture Of Businesses Net Of Cash Divested ProceedsFromDivestitureOfBusinessesNetOfCashDivested	0	USD
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	34952000	USD
CY2016	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	225000000	USD
CY2017	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	250000000	USD
CY2018	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	1325383000	USD
CY2016	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-973000	USD
CY2017	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	-865000	USD
CY2018	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	360000	USD
CY2018	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3797000	USD
	us-gaap	Profit Loss ProfitLoss	-148709000	USD
CY2016	us-gaap	Profit Loss ProfitLoss	209426000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	42261000	USD
CY2017Q2	us-gaap	Profit Loss ProfitLoss	37748000	USD
CY2017Q3	us-gaap	Profit Loss ProfitLoss	27122000	USD
CY2017Q4	us-gaap	Profit Loss ProfitLoss	62194000	USD
CY2017	us-gaap	Profit Loss ProfitLoss	169325000	USD
CY2018Q1	us-gaap	Profit Loss ProfitLoss	51652000	USD
CY2018Q2	us-gaap	Profit Loss ProfitLoss	-250090000	USD
CY2018Q3	us-gaap	Profit Loss ProfitLoss	17465000	USD
CY2018Q4	us-gaap	Profit Loss ProfitLoss	-20330000	USD
CY2018	us-gaap	Profit Loss ProfitLoss	-201303000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	643128000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	753582000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	486758000	USD
CY2018Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	544146000	USD
CY2017Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2018Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	USD
CY2016	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	11137000	USD
CY2017	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	13625000	USD
CY2018	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	617051000	USD
CY2018	us-gaap	Restructuring Charges RestructuringCharges	56413000	USD
CY2016	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-382785000	USD
CY2018Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20920000	USD
CY2017	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0	USD
CY2018Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	413787000	USD
CY2016	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1018225000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	225681000	USD
CY2018Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	476487000	USD
CY2018Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	497528000	USD
CY2018	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	92042000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	179019000	USD
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3797000	USD
CY2017Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	259871000	USD
CY2018	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1662991000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	118757000	USD
CY2017Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	254733000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	171420000	USD
CY2018	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	194190000	USD
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	11708000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	504750000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	10179000	USD
CY2017Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	3756000	USD
CY2018Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	5385000	USD
CY2016	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2017	us-gaap	Restructuring Charges RestructuringCharges	0	USD
CY2017Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	293369000	USD
CY2017	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1033654000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	275189000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	109046000	USD
CY2018	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	230435000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	0	USD
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	167597000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y3M12D
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2438046	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	19.37
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3000000	USD
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	392228	shares
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3555808	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2600000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	0	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	5814581	shares
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.00
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.73
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	10.80
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.02
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	16.64
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2600000	USD
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	351668	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1490232000	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	896363000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	182000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2016	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2017	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	0	USD
CY2018	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	1176000	USD
CY2018	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	67000	USD
CY2018Q4	us-gaap	Undistributed Earnings Of Foreign Subsidiaries UndistributedEarningsOfForeignSubsidiaries	56000000	USD
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7000000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	7206000	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Acquisition UnrecognizedTaxBenefitsIncreasesResultingFromAcquisition	5208000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	0	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	2346000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Accrued UnrecognizedTaxBenefitsInterestOnIncomeTaxesAccrued	600000	USD
CY2018	us-gaap	Unrecognized Tax Benefits Interest On Income Taxes Expense UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense	200000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2017	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	0	USD
CY2018	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	530000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	7000000	USD
CY2016	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted		shares
CY2018	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	127252000	shares
CY2018	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Reclassifications </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Certain prior period balances have been reclassified to conform to the current period presentation, including combining depreciation and amortization expense into the respective cost of goods sold, selling, general and administrative and R&D expense presentation on the consolidated statements of operations, as well as combining accounts payable and accrued expenses and combining long-term debt and revolving credit facility in the balance sheet presentation. </font></div></div>
CY2018	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company's management to make estimates and assumptions that affect the reported financial position at the date of the financial statements and the reported results of operations during the reporting period. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses, and disclosure of contingent assets and liabilities in the consolidated financial statements and accompanying notes. The following are some, but not all, of such estimates: the determination of chargebacks, sales returns, rebates, bill backs, allowances for accounts receivable, accrued liabilities, stock-based compensation, valuation of inventory balances, the determination of useful lives for product rights and the assessment of expected cash flows used in evaluating goodwill and other long-lived assets for impairment. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001723128-19-000028-index-headers.html	Edgar Link	pending
0001723128-19-000028-index.html	Edgar Link	pending
0001723128-19-000028.txt	Edgar Link	pending
0001723128-19-000028-xbrl.zip	Edgar Link	pending
amendmentno1tothirdamended.htm	Edgar Link	pending
amneal-formpsuawardagreeme.htm	Edgar Link	pending
amrx-12x31x201810kdoc.htm	Edgar Link	pending
amrx-12x31x2018x10kxex311s.htm	Edgar Link	pending
amrx-12x31x2018x10kxex312b.htm	Edgar Link	pending
amrx-12x31x2018x10kxex321s.htm	Edgar Link	pending
amrx-12x31x2018x10kxex322b.htm	Edgar Link	pending
amrx-12x31x2018xex211.htm	Edgar Link	pending
amrx-12x31x2018xex231.htm	Edgar Link	pending
amrx-20181231.xml	Edgar Link	completed
amrx-20181231.xsd	Edgar Link	pending
amrx-20181231_cal.xml	Edgar Link	unprocessable
amrx-20181231_def.xml	Edgar Link	unprocessable
amrx-20181231_lab.xml	Edgar Link	unprocessable
amrx-20181231_pre.xml	Edgar Link	unprocessable
chart-fa87be64a3dcb99bed5a05.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
separationagreementclean2-.htm	Edgar Link	pending
separationagreementreasons.htm	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx

2017 Q4 Form 10-K Financial Statement

#000172312819000028 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX Amneal Pharmaceuticals, Inc. Stock $amrx

2017 Q4 Form 10-K Financial Statement

#000172312819000028 Filed on March 01, 2019

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMRX
Amneal Pharmaceuticals, Inc. Stock $amrx